glp-1 naion Andrew Lee, MD GLP-1 Medications and NAION: What

Exposures Each GLP-1 RA new user was propensity score matched in 1:1 ratio to a patient who initiated a DPP-4i during the same month

Consider starting with a smaller dose

The medications have not been approved by the FDA for this indication, and healthcare providers stress that adding semaglutide to an existing alcohol use disorder without proper medical supervision could mask serious health conditions or delay evidence-based addiction treatment

Compounded semaglutide is not FDA-approved, is not the same as these brand-name products, and has not been reviewed by the FDA for safety or effectiveness

That for so long obesity was you're just being lazy, why don't you move more, why don't you eat better